Within WFI loops, the potential for biofilm development is a critical threat that is primarily caused by laminar flow and the presence of dead zones in the pipework. Bürkert’s business development manager for pharma & biotech, Damien Moran, explains.
Just when pharmaceutical supply chains had begun to recover from the chaos of the pandemic, companies are now faced with the threat of US tariffs and the ongoing investigation into the United States’ reliance on drug imports.
European Pharmaceutical Manufacturer asks John McDermott, vice president of scientific consulting at Quotient Sciences what the benefits are of using a CRDMO?
Europe’s rollout of ISO IDMP product data standards is well underway now, and EMA’s aligned Product Management Services (PMS) platform, now live, is the next priority - with deadlines for enriching existing data hitting from the end of this year.
Roger Gaemperle, industry strategy & marketing manager – consumer packaged goods & life science EMEA at Rockwell Automation discusses the role of MES in biopharma.
Updesh Dosanjh, practice leader, Pharmacovigilance Technology Solutions, IQVIA explains how Artificial intelligence (AI) is now deeply embedded in pharmaceutical operations, especially in pharmacovigilance.
During a visit to Fujifilm’s Tilburg site this month, I was able to witness something that’s not only innovative from a sustainability standpoint - but also could be a game-changer for pharmaceutical manufacturing.
